Kang Luo

Statistics

Publications

Citations

1.8K

H-Index

Active since

2005

Affiliations

Nanjing Medical University(Current)

Kang Luo is an author at Nanjing Medical University specializing in vascular endothelial growth factor inhibition, heavy metal toxicology, and growth factor signaling.

ORCID

Publications per year

2005–2013

Publications

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

George Lau, Teerha Piratvisuth, Kang Luo et al. · New England Journal of Medicine · 2005 · 1.5K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

The protective effects of selenium on cadmium-induced oxidative stress and apoptosis via mitochondria pathway in mice kidney

Yang Wang, Yuchen Wu, Kang Luo et al. · Food and Chemical Toxicology · 2013 · 161 citations

Pharmacy, Cell Biology, Toxicology +16

The protection of selenium on cadmium-induced inhibition of spermatogenesis via activating testosterone synthesis in mice

Xiangmei Ren, Gaigai Wang, Dongqing Xu et al. · Food and Chemical Toxicology · 2012 · 72 citations

Veterinary Medicine, Biochemistry, Toxicology +14

Liquiritigenin Inhibits Tumor Growth and Vascularization in a Mouse Model of Hela Cells

Yuxin Liu, Sirou Xie, Yu Wang et al. · Molecules · 2012 · 55 citations · Full text

Medicine, Oncology, Pharmacology +14

Liquiritigenin Inhibits Serum‐induced HIF‐1α and VEGF Expression via the AKT/mTOR‐p70S6K Signalling Pathway in HeLa Cells

Sirou Xie, Yu Wang, Changwei Liu et al. · Phytotherapy Research · 2011 · 31 citations

Medicine, Oncology, Pharmacology +15

1–5 of 5